PD-L1 Quantitative by IHC

CPT: 88360
Print Share

Synonyms

  • PD-L1 Non-specific

Special Instructions

Note: This test number is used for tracking oncology IHC specimens to the laboratory. Bill codes will be added when testing is complete, based on the processes performed in the laboratory.


Expected Turnaround Time

1 - 2 days


Specimen Requirements


Specimen

Formalin-fixed paraffin-embedded (FFPE) tissue block or slides


Volume

One tissue block or five unstained positively charged slides less than one month in age


Minimum Volume

At least three unstained slides sectioned at 4-5 microns


Container

Paraffin block or unstained positive charged slides


Collection

Paraffin block or unstained slides sectioned of no more than one month age.


Causes for Rejection

Slides sectioned greater than one month prior to test request


Test Details


Use

PD-L1 overexpression is associated with adverse prognosis in solid tumors, though specific prognosis varies among different tumor types. The utility of this PD-L1 (22C3) assay in predicting the response to therapy has not been determined for all tumor types, and standardized scoring methods do not exist for all tumor types.


Limitations

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.


Methodology

Immunohistochemistry


References

Wang Q, Liu F, Liu L. Prognostic significance of PD-L1 in solid tumor: an updated meta-analysis. Medicine (Baltimore). 2017 May;96(18):e6369.28471952
Wu P, Wu D, Li L, Chai Y, Huang J. PD-L1 and survival in solid tumors: a meta-analysis. PLoS One. 2015 Jun 26;10(6):e013140.26114883

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
452366 PD-L1 Quantitative by IHC 452367 Referring Physician 18781-5
452366 PD-L1 Quantitative by IHC 452368 Treating Physician 18781-5
452366 PD-L1 Quantitative by IHC 452369 Client Specimen ID 48767-8
452366 PD-L1 Quantitative by IHC 452370 Contain(s) Received 74384-9
452366 PD-L1 Quantitative by IHC 452371 Clinical Data 55752-0
452366 PD-L1 Quantitative by IHC 452372 Revision Text N/A
452366 PD-L1 Quantitative by IHC 452373 Body Site 39111-0
452366 PD-L1 Quantitative by IHC 452374 Specimen Type 66746-9
452366 PD-L1 Quantitative by IHC 452375 Interpretation 50595-8
452366 PD-L1 Quantitative by IHC 452376 Test(s) Cancelled N/A
452366 PD-L1 Quantitative by IHC 452378 Comments: 77202-0
452366 PD-L1 Quantitative by IHC 452379 Reviewing Pathologist 19139-5
452366 PD-L1 Quantitative by IHC 452380 General Results 19146-0
452366 PD-L1 Quantitative by IHC 452381 Result 55229-9
452366 PD-L1 Quantitative by IHC 452382 Non Standard Comments 8251-1
452366 PD-L1 Quantitative by IHC 452383 Additional Notation 48767-8
452366 PD-L1 Quantitative by IHC 452384 Electronically Signed by 19139-5
452366 PD-L1 Quantitative by IHC 452385 Proxy Release by 19139-5
452366 PD-L1 Quantitative by IHC 452386 Disclaimer 62364-5
452366 PD-L1 Quantitative by IHC 452387 PDF 11502-2
452366 PD-L1 Quantitative by IHC 452103 Bill Code Entry Hold N/A

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf